Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2017
Price : $35 *
At a glance
- Drugs Aspirin/sumatriptan (Primary)
- Indications Headache
- Focus Therapeutic Use
- 05 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2016, according to ClinicalTrials.gov record.
- 24 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.